
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RQ2712KSM) is a sirolimus-eluting coronary stent system with a 2.75 mm nominal diameter and 12 mm stent length, mounted on a rapid-exchange (monorail) delivery catheter. It is designed to support percutaneous coronary intervention workflows where deliverability, conformability, and controlled drug release are priorities.
Key Features
- Drug: Sirolimus as the antiproliferative agent
- Bioresorbable abluminal polymer coating (PDLLA-PCL) for abluminal-only drug elution
- Cobalt-chromium thin-strut stent platform for low crossing profile
- Rapid-exchange monorail delivery system
- Nominal diameter: 2.75 mm; stent length: 12 mm
- Radiopaque markers to support fluoroscopic placement
- Pre-mounted, single-use, sterile configuration
Clinical Applications
- Percutaneous coronary intervention (PCI) in native coronary arteries
- Treatment of de novo coronary artery lesions within the labeled vessel range
- Support for operators seeking a thin-strut drug-eluting stent with abluminal bioresorbable polymer
- Use should follow the manufacturer's Instructions for Use and local regulatory labeling
Product Information
- Brand: Terumo
- Product line: Ultimaster Nagomi
- Category: Coronary Stents / Drug-Eluting Stents
- REF / UPN: DE-RQ2712KSM
- Size: 2.75 mm x 12 mm
- Delivery system: Rapid-exchange (monorail)
- Guide wire compatibility: 0.014 in (as per Ultimaster family IFU)
- Recommended guiding catheter: Not specified in the located sources for this specific REF; refer to IFU
- Rated burst pressure / nominal pressure: Not specified in the located sources for this specific REF; refer to IFU
- Sterilization: Sterile, single-use
- Regulatory status: Refer to local regulatory labeling and IFU prior to use
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.